14:00 - 16:30
UK is one of the most interesting markets in Europe today, with a long and outstanding collaboration with Norway. What does Brexit mean and will it give new opportunities for Norwegian companies?
Join us for an interesting and informative meeting about the UK market by meeting experts and key opinion leaders. They will give you insight in how the current situation can impact your go-to-market strategy.
We think Brexit and its possible consequences also means that the UK as a market is more interested than ever before to develop a closer collaboration with Norwegian health companies. Brexit can therefore be a window of opportunity.
The meeting is held in collaboration with the British Embassy in Norway.
Sign up now for 1:1-meetings with the UK-experts.
14.00 Welcome by/Kathrine Myhre, CEO Norway Health Tech
14.20 Mr. Chris Howie from European Life Science Specialist at Department for International Trade (UK) will talk about the UK Life Science offering. He will give an overview of the NHS as well as a Brexit update.
14.50 David D’Alton ,CEO at D’Alton Kingswell Ltd will focus on London’s position to raise private finance for Life Science SME’s and start-ups.
15.20 Experiences from the UK, through the eyes of a Norwegian health tech company.
15.50 1:1-meetings with David d’Alton and Chris Howie in Hagen 1 and Meetingbox at Norway Health Tech.
16.30 The end.Register